Yunuo Zhao
Overview
Explore the profile of Yunuo Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li G, Jiang Y, Tong H, Liu J, Jiang Z, Zhao Y, et al.
Drug Resist Updat
. 2025 Feb;
79:101212.
PMID: 39951881
Aims: Triple-negative breast cancer (TNBC) has shown resistance to immunotherapy. Stimulating ProkR2-bearing sensory neurons of the sciatic nerve has been reported to regulate immune function by catecholamine release through the...
2.
Zhao Y, Zhang B
Eur J Med Res
. 2024 Dec;
29(1):630.
PMID: 39726025
Background: Abnormal body temperature (fever or hypothermia) is a critical symptom in sepsis and is strongly associated with clinical prognosis and disease progression. Given the duality and variability of body...
3.
Tong H, Jiang Z, Song L, Tan K, Yin X, He C, et al.
Cell Metab
. 2024 Nov;
36(12):2493-2510.e9.
PMID: 39577415
The effect of the serine/glycine-free diet (-SG diet) on colorectal cancer (CRC) remains unclear; meanwhile, programmed death-1 (PD-1) inhibitors are less effective for most CRC patients. Here, we demonstrate that...
4.
Jiang Z, Kang Q, Qian H, Xu Z, Tong H, Yang J, et al.
Signal Transduct Target Ther
. 2024 Aug;
9(1):193.
PMID: 39090109
Cardiac myxoma is a commonly encountered tumor within the heart that has the potential to be life-threatening. However, the cellular composition of this condition is still not well understood. To...
5.
Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y, et al.
Cancer Cell
. 2023 Jan;
41(2):272-287.e9.
PMID: 36706761
Circulating tumor cells (CTCs), shed by primary malignancies, function as "seeds" for distant metastasis. However, it is still largely unknown how CTCs escape immune surveillance. Here, we characterize the transcriptomes...
6.
Yang Y, Zhao Y, Liu X, Huang J
Semin Cancer Biol
. 2022 Nov;
87:137-147.
PMID: 36372326
Artificial intelligence (AI) indicates the application of machines to imitate intelligent behaviors for solving complex tasks with minimal human intervention, including machine learning and deep learning. The use of AI...
7.
Zheng A, Wei Y, Zhao Y, Zhang T, Ma X
Front Immunol
. 2022 Oct;
13:1013506.
PMID: 36268019
Ovarian cancer is currently one of the most common malignant tumors in females with poor survival rates around the world, killing about 200,000 women each year. Although great progress has...
8.
Li Q, Chen L, Jin H, Zhao Y, Hao Z, Ma X
Clin Med Insights Oncol
. 2022 Mar;
16:11795549221084851.
PMID: 35355514
Introduction: Pretreatment inflammatory markers were applied to predict the prognosis of colorectal cancer. However, the role of these markers in predicting survival in patients with synchronous colorectal liver metastasis (CLM)...
9.
Zhu S, Zhao Y, Quan Y, Ma X
Front Surg
. 2021 Dec;
8:783218.
PMID: 34957205
Myeloid-derived suppressor cells (MDSCs) are known to play an essential part in tumor progression under chronic stress settings through their manipulation of adaptive and innate immune systems. Previous researches mainly...
10.
Li Z, Wu X, Zhao Y, Xiao Y, Zhao Y, Zhang T, et al.
MedComm (2020)
. 2021 Nov;
2(1):60-68.
PMID: 34766136
PD-1/PD-L1 (programmed cell death-1 and programmed death-ligand 1) inhibitors utilization in neoadjuvant therapy has been assessed in tumors. This study focused on the clinical benefits of neoadjuvant anti-PD-1/PD-L1 therapy. A...